In this paper, we examine whether PNO1 can be used as a biomarker for HCC and examine the molecular mechanisms by which PNO1 inhibition regulates HCC growth and epithelial‐mesenchymal transition (EMT). This evidence concerns the gene PNO1 and hepatocellular carcinoma.